Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / celularity ceo to present on cell therapy s potentia mwn benzinga


CELUW - Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit | Benzinga

  • FLORHAM PARK, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) ("Celularity" or the "Company"), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced today that the Company's Founder and CEO, Dr. Robert Hariri, M.D., Ph.D., will present on the promise of cellular therapy to improve longevity at this year's ABUNDANCE Summit on March 21, 2024.

    Dr. Hariri's presentation, titled "The Cell Therapy Basis for Longevity," will discuss the potential for using cellular therapeutics to address the biological ravages of aging by combating immunosenescence, sarcopenia and degenerative diseases. Dr. Hariri has led the effort to harness the unique biology of placental-derived cells in a range of clinical indications, including cancer, autoimmune and degenerative diseases. Dr. Hariri will also discuss how cellular therapeutics derived from newborn cells from the placenta can shift the biology of aging with the potential to extend and preserve human performance with age.

    "Celularity continues to invest in the research behind cellular immunotherapy, which looks at how stem and immune cells can be used to regenerate failing organs or damaged tissues that occur with various age-related degenerative disorders and diseases," said Dr. Hariri. "We pioneered the use of cells derived from the postpartum placenta, including stem and immune cells, and today, Celularity's Lifebank newborn cell banking division is the world's largest repository of autologous placental-derived cells. We believe that scientists have only scratched the surface in terms of understanding cellular immunotherapy's full potential for improving longevity."

    "The field of cellular medicine is uniquely poised to revolutionize medicine as a whole through augmenting our biology, immunity, and longevity," added Dr. Peter Diamandis, M.D., Abundance360 and Singularity University Founder. "Dr. Hariri has been a ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Celularity Inc. Warrant
    Stock Symbol: CELUW
    Market: NASDAQ
    Website: celularity.com

    Menu

    CELUW CELUW Quote CELUW Short CELUW News CELUW Articles CELUW Message Board
    Get CELUW Alerts

    News, Short Squeeze, Breakout and More Instantly...